Materias dentro de su búsqueda.
Mostrando 901 - 920 Resultados de 5,148 Para Buscar '"Ph.D"', tiempo de consulta: 0.31s Limitar resultados
  1. 901
    “…Ruth Chapman, MSc, PhD, Evidera, Inc, (Evidera, Inc. received the funding to conduct this study.) …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1394. Impact of 7-Valent and 13-Valent Pneumococcal Conjugate Vaccines in the United States: A Systematic Literature Review
  2. 902
    “…Pride, PhD, Pfizer (Employee, Shareholder) Ingrid L. Scully, PhD, Pfizer Inc (Employee, Shareholder) Kathrin U. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    3. Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older
  3. 903
    “…Seasonal influenza efficacy [Image: see text] DISCLOSURES: James Levin, PhD, Cidara Therapeutics (Shareholder) Karin Amundson, BSc, Cidara Therapeutics (Shareholder) Allen Borchardt, PhD, Cidara Therapeutics (Employee) Thanh Lam, PhD, Cidara Therapeutics (Shareholder) Tom Brady, PhD, Cidara Therapeutics (Shareholder) Alain Noncovich, PhD, Cidara Therapeutics (Shareholder) Les Tari, PhD, Cidara Therapeutics (Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    159. efficacy of CD377, a Novel Antiviral Fc-conjugate, Against Seasonal Influenza in Lethal Mouse Infection Models
  4. 904
    “…(Employee) Ryan Gan, PhD, F. Hoffmann-La Roche Ltd (Shareholder)Genentech, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States
  5. 905
    “…(Advisor or Review Panel member) Galia Rahav, MD, AstraZeneca (Scientific Research Study Investigator) Nicolas De Schryver, MD, AstraZeneca (Scientific Research Study Investigator) Alain Lepape, MD, AstraZeneca (Scientific Research Study Investigator) Miguel Sanchez Garcia, MD, PhD, AstraZeneca (Scientific Research Study Investigator) Antoni Torres, MD, PhD, AstraZeneca (Scientific Research Study Investigator) Omar Ali, PhD, AstraZeneca (Employee) Kathryn Shoemaker, MS, AstraZeneca (Employee) Alexey Ruzin, PhD, AstraZeneca (Employee, Shareholder) Yu Jiang, PhD, AstraZeneca (Employee) Susan Colbert, BSN, AstraZeneca (Employee) Drieke Vandamme, PhD, AstraZeneca (Scientific Research Study Investigator) Terramika Bellamy, n/a, AstraZeneca (Employee) Colin Reisner, MD, AstraZeneca (Employee) Filip Dubovsky, MD, MPH, AstraZeneca (Employee) Hasan S. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    635. Efficacy, Pharmacokinetics (PK), and Safety Profile of MEDI3902, an Anti-Pseudomonas aeruginosa Bispecific Human Monoclonal Antibody in Mechanically Ventilated Intensive Care Unit Patients; Results of the Phase 2 EVADE Study Conducted by the Public-Private COMBACTE-MAGNET Consortium in the Innovative Medicines Initiative (IMI) Program
  6. 906
    “…DISCLOSURES: Jeroen Geurtsen, PhD, Janssen: Employee|Janssen: Stocks/Bonds Joachim Doua, MD, MPH, Janssen: Employee|Janssen: Stocks/Bonds Patricia Ibarra de Palacios, MD, Janssen: Employee at the time of analysis Matthew Sims, MD, PhD, Astra-Zeneca: Investigator for company-sponsored studies|ContraFect: Investigator for company-sponsored studies|Crestone: Investigator for company-sponsored studies|Finch: Investigator for company-sponsored studies|Janssen: Investigator for company-sponsored studies|Leonard-Meron: Investigator for company-sponsored studies|Merck and Co: Investigator for company-sponsored studies|OpGen Inc: Advisor/Consultant|OpGen Inc: Investigator for company-sponsored studies|Pfizer: Investigator for company-sponsored studies|Prenosis: Advisor/Consultant|Prenosis: Investigator for company-sponsored studies|QIAGEN Sciences LLC: Investigator for company-sponsored studies|Roche: Investigator for company-sponsored studies|Seres Therapeutics: Investigator for company-sponsored studies Peter Hermans, PhD, Janssen: Employee at the time of analysis Joshua T. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2465. O-serotype Distribution of Escherichia coli Causing Invasive Disease in Tertiary Care Hospital Patients
  7. 907
    “…It aims at introducing advanced graduate and PhD students, as well as young researchers, to current research in mathematics and physics. …”
    Enlace del recurso
    From classical mechanics to quantum field theory: a tutorial
  8. 908
    por Smathers, Jim
    Publicado 2001
    “…Edited by Almon Shiu, Ph.D. and David Mellenberg Ph.D., 356 pp. Medical Physics Publishing, Madison, WI. 1998. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Book Review
  9. 909
    “…Background and study aims Physician-directed nurse-administered balanced propofol sedation (PhD NAPS) in patients undergoing endoscopy and/or colonoscopy is being increasingly utilized worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessing the safety of physician-directed nurse-administered propofol sedation in low-risk patients undergoing endoscopy and colonoscopy
  10. 910
    “…The purpose of the 10,000 PhDs Project was to determine the current (2016) employment status of the 10,886 individuals who graduated from the University of Toronto with a PhD in all disciplines from 2000–2015. Using internet searches, we found that about half (51%) of the PhD graduates are employed in the post-secondary education sector, 26% as tenure-track professors, with an additional 3% as adjunct professors and 2% as full-time teaching-stream professors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The 10,000 PhDs project at the University of Toronto: Using employment outcome data to inform graduate education
  11. 911
    “…In this article, we describe the impact of the Washington University journal club on the education of first year MD‐PhD students and summarize the progress to date. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The time is now: Student‐driven implementation of social justice and anti‐racism focused curricula in medical scientist training program education
  12. 912
    “…Glenn S. Tillotson, PhD, Dynavax: Advisor/Consultant|Ferring Pharmaceuticals: Advisor/Consultant|Peggy Lillis Foundation: Honoraria|Spero Therapeutics: Advisor/Consultant Yipeng Gao, PhD, Merck and Co.: Grant/Research Support Erik R. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    366. Association Between Gut Microbiota and Health-Related Quality of Life in Patients with Recurrent Clostridioides difficile Infection: Results from the PUNCH CD3 Clinical Trial
  13. 913
    “…DISCLOSURES: Kazuko Yamamoto, MD, PhD, Fisher & Paykel Healthcare: Grant/Research Support|Kirin Holdings Co.: Grant/Research Support Tsuyoshi Inoue, MD, PhD, Kirin Holdings Co.: Grant/Research Support|Kyowa Kirin Co.: donated course Kenta Jounai, PhD, Kirin Holdings Co.: Employee Ryohei Tsuji, PhD, Kirin Holdings Co.: Employee Daisuke Fujiwara, PhD, Kirin Holdings Co.: Employee Katsunori Yanagihara, MD, PhD, FUJIFILM Toyama Chemical Co., Ltd.: Commissioned research|KYORIN Pharmaceutical Co.,Ltd.: Commissioned research Koichi Izumikawa, M.D., Ph.D., Asahi Kasei Pharma Corporation: Grant/Research Support|Asahi Kasei Pharma Corporation: Honoraria|Astellas Pharma Inc.: Honoraria|DAIICHI SANKYO COMPANY, LIMITED: Grant/Research Support|DAIICHI SANKYO COMPANY, LIMITED: Honoraria|KYORIN Pharmaceutical Co.,Ltd.: Honoraria|Merck & Co., Inc.: Honoraria|Pfizer Japan Inc.: Honoraria|Shionogi & Co., Ltd.: Grant/Research Support|Shionogi & Co., Ltd.: Honoraria|Sumitomo Pharma Co., Ltd.: Grant/Research Support|Sumitomo Pharma Co., Ltd.: Honoraria|TAIHO PHARMACEUTICAL CO., LTD.: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study)
  14. 914
    “….: Stocks/Bonds Wenmei Huang, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Jia Guo, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Evelyn Du, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Andrei Avanesov, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Sinead Rudden, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Bryony Hicks, BSc, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Greg Livermore, BS, MBA, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Kristi Schaefers, BIS, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Mary Lau, BS, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Raffael Nachbagauer, MD, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Jintanat Ananworanich, MD, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1639. A Review of Clinical Safety, Reactogenicity, and Immunogenicity of an mRNA-Based Seasonal Influenza Vaccine (mRNA-1010) in Adults
  15. 915
    “…DISCLOSURES: Jakub Simon, MD, MS, Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Stephen Kennedy, MD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Scientific Research Study Investigator) Barbara Mahon, MD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Sheri Dubey, MS, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Rebecca Grant-Klein, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Ken Liu, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Jonathan Hartzel, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Beth-Ann Coller, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Carolee Welebob, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Mary Hanson, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder) Rebecca Grais, PhD, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Scientific Research Study Investigator)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials
  16. 916
    “…Esser, PhD, AstraZeneca: Employee|AstraZeneca: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study
  17. 917
    “…Wells, MPH, PhD Candidate, Biotia, Inc.: Employee David C. Danko, Ph.D., Biotia Inc: Stocks/Bonds Niamh B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2835. Utilization of Clinical-Grade Metagenomics in Urinary Tract Infection Diagnostics: Improving High-Risk Patients’ Outcomes with a Genomic-Based Assay
  18. 918
    “…DISCLOSURES: Tahel Ilan Ber, MD, MeMed (Employee) Alon Angel, n/a, MeMed (Employee) Lior Kellerman, M.D, MeMed (Employee) Eran Barash, MA, MeMed (Employee) Roy Navon, MSc, MeMed (Employee) Einav Simon, PhD, MeMed (Employee) Noa Avni, PhD, MeMed (Employee) Mary Hainrichson, PhD, MeMed (Employee) Tanya Gottlieb, PhD, MeMed (Employee) Kfir Oved, MD, PhD, MeMed (Employee) Eran Eden, PhD, MeMed (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    426. Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients
  19. 919
    “…Willer, PhD, GSK group of companies (Employee, Other Financial or Material Support, Receive GSK shares as part of employment renumeration) Wivine Burny, PhD, GSK group of companies (Employee) Caroline Hervé, PhD, GSK group of companies (Employee) Joon Hyung Kim, MD, GSK group of companies (Employee, Shareholder) myron J. levin, MD, GSK group of companies (Employee, Research Grant or Support) Toufik Zahaf, PhD, GSK group of companies (Employee, Shareholder) Anthony L. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
  20. 920
    “…(Employee, Shareholder) Elizabeth Halvorsen, PhD, Seres Therapeutics (Employee, Shareholder) Mary-Jane Lombardo, PhD, Seres Therapeutics (Employee, Shareholder) Jonathan Winkler, PhD, Seres Therapeutics (Employee, Shareholder) Barbara McGovern, MD, Seres Therapeutics (Employee, Shareholder) Gregory McKenzie, PhD, Prolacta Bioscience (Employee) David Ege, PhD, Merck & Co., Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1035. Manufacturing Processes of SER-109, a Purified Investigational Microbiome Therapeutic, Reduce Risk of Transmission of Emerging and Undetected Infections in Donor Stool
Herramientas de búsqueda: RSS